Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects.
- 2025-05-02
- RCT · n = 99
- GeroScience 48(1)
- Miguel German Borda
- Robinson Ramírez-Vélez
- Felipe Botero-Rodriguez
- Jonathan Patricio-Baldera
- Chiara de Lucia
- Ilaria Pola
- George E Barreto
- Khadija Khalifa
- Anne Katrine Bergland
- Miia Kivipelto
- Tommy Cederholm
- Henrik Zetterberg
- Nicholas J Ashton
- Clive Ballard
- Richard Siow
- Dag Aarsland
- PubMed: 40314845
- DOI: 10.1007/s11357-025-01669-8
- High evidence
- Clinical
ANCOVA analyses reveal 24-week differences favoring the anthocyanin treatment in ... Inflam z-score 5 (ƞp2=0.059, p=0.004)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 320 mg/day